# Acuity News: Your \#1 Source For Behavioral Health News > Acuity News delivers breaking coverage of the behavioral health and ABA therapy industry — M\&A deals, Medicaid policy, autism care regulation, and technology trends for executives, investors, and providers\. Generated by Yoast SEO v28.0, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [About](https://acuity.news/about/): We inform decision\-makers, investors, and innovators in behavioral health through an editorially independent platform\. - [Home](https://acuity.news/) - [Sponsor ROI Calculator](https://acuity.news/roi-calculator/) - [Media Kit](https://acuity.news/media-kit/): Connect your brand with the executives, investors, and decision\-makers driving the future of behavioral health - [Contact](https://acuity.news/contact/): Contact Acuity Media Network for general questions or to request an advertising media kit\. ## Posts - [Autism\-Friendly Dental Care in New Jersey Runs on Individual Heroics\. Autism New Jersey and the New Jersey Dental Foundation Are Trying to Build a System\.](https://acuity.news/regulation/autism-friendly-dental-care-new-jersey-initiative/): Dental care remains the single most frequently reported unmet healthcare need among autistic individuals\. In New Jersey, where CDC surveillance data indicates an autism prevalence of 1 in 29 among eight\-year\-olds, accessing routine oral healthcare often requires families to travel long distances or navigate complex operating room sedation backlogs\. To replace reliance on individual provider goodwill with an integrated system, Autism New Jersey and the New Jersey Dental Foundation are deploying a statewide initiative centered on clinical self\-assessments, provider education, and cross\-disciplinary desensitization\. - [Small ABA Practice Closures Leave Almost No Public Record While the Industry Counts Every Acquisition\. Fixed Compliance Costs Land Hardest Where There Is No Scale\.](https://acuity.news/regulation/small-aba-practice-closures-uncounted-compliance-costs/): While healthcare M\&A trackers meticulously document every private equity acquisition in the Applied Behavior Analysis \(ABA\) space, no dataset monitors the quiet closure of solo and small practices\. As regulatory requirements shift from variable costs to steep, fixed overhead—including physical facility mandates in Alabama and mandatory national accreditation in Massachusetts—unscaled practices face an existential squeeze\. Without capital runway or dedicated legal support to absorb Medicaid payment holds and retrospective audits, small operators are exiting the market with virtually no public record\. - [Medicaid Reentry Waivers Are Opening a New Market in Addiction Care\. The Weeks After Release Are the Deadliest for Overdose, and Coverage Now Reaches Through the Gate\.](https://acuity.news/regulation/medicaid-reentry-waivers-incarceration-overdose-sud-care-2026/): The transition from incarceration back into community life represents one of the most lethal gaps in addiction medicine, marked by a massive spike in fatal overdoses during the first weeks following release\. To eliminate this coverage cliff, federal regulators have cleared Section 1115 demonstration waivers in 19 states, allowing Medicaid to fund targeted substance use disorder \(SUD\) services up to 90 days before release\. Paired with a mandatory federal "suspend\-not\-terminate" policy taking effect in 2026, this policy evolution breaks down historical inmate exclusion barriers to create a vital, federally backed care\-coordination market\. - [GLP\-1 Drugs for Addiction Are Moving From Anecdote to Evidence\. A 2026 Trial Suggests Semaglutide Can Blunt the Urge to Drink\.](https://acuity.news/regulation/glp1-semaglutide-alcohol-use-disorder-addiction-evidence-2026/): What began as a scattered wave of real\-world patient anecdotes has solidified into an empirical reality for the addiction medicine landscape\. A landmark 2026 double\-blind, randomized trial published in The Lancet has delivered the most definitive clinical signal to date: once\-weekly semaglutide injections significantly reduce heavy drinking days and self\-reported cravings in adults navigating alcohol use disorder and comorbid obesity\. While federal regulatory approvals remain anchored to metabolic and diabetes care, this study challenges providers and payers to prepare for a paradigm shift in addiction therapeutics\. - [CMS’s Proposed 2027 Medicare Fee Schedule Adds Six New ABA CPT Codes for Harmful Behavior and Analyst Work\. Carrier Pricing Continues Through 2027, Leaving ABA Rates With Payers\.](https://acuity.news/regulation/cms-proposed-2027-medicare-fee-schedule-aba-cpt-codes/): The Centers for Medicare \& Medicaid Services \(CMS\) has published the proposed rule for the Calendar Year 2027 Medicare Physician Fee Schedule, introducing a major evolution in adaptive behavior healthcare coding\. Validating a series of procedural definitions approved by the AMA’s CPT Editorial Panel, the federal rule integrates six brand\-new CPT codes primarily optimized to evaluate and treat high\-acuity, harmful behaviors\. Crucially for providers, CMS has simultaneously extended decentralized carrier pricing, ensuring that absolute rate\-setting remains a matter of localized negotiation with commercial insurers and state Medicaid agencies\. ## AdSanity: Ads - [Marsh McLennan Desktop Banner](https://acuity.news/ads/marsh-mclennan/) - [Marsh McLennan Mobile and Sidebar Ad](https://acuity.news/ads/marsh-mclennan-mobile-and-sidebar-ad/) - [Acuity Banner Ad \- Desktop](https://acuity.news/ads/acuity-banner-ad-desktop/) - [Mobile \- Sign Up for Acuity Newsletter](https://acuity.news/ads/mobile-sign-up-for-acuity-newsletter/) - [Footer Mobile \- Sign Up for Acuity Newsletter](https://acuity.news/ads/footer-mobile-sign-up-for-acuity-newsletter/) ## Categories - [Regulation](https://acuity.news/category/regulation/) - [Technology](https://acuity.news/category/technology/) - [M\&A](https://acuity.news/category/m-and-a/) ## Tags - [Main Featured](https://acuity.news/tag/main-featured/) - [Featured](https://acuity.news/tag/featured/) - [ABA](https://acuity.news/tag/aba/) - [Applied Behavior Analysis](https://acuity.news/tag/applied-behavior-analysis/) - [Private Equity](https://acuity.news/tag/private-equity/) ## Categories - [DiviMenus](https://acuity.news/layout_category/divimenus/) - [General Content Sections](https://acuity.news/layout_category/general-content-sections/) ## Type - [section](https://acuity.news/layout_type/section/) - [module](https://acuity.news/layout_type/module/) - [row](https://acuity.news/layout_type/row/) - [layout](https://acuity.news/layout_type/layout/) ## Module Width - [regular](https://acuity.news/module_width/regular/) ## Scope - [not\_global](https://acuity.news/scope/not_global/) - [global](https://acuity.news/scope/global/) ## AdSanity: Ad Groups - [Sidebar](https://acuity.news/ad-group/sidebar/) - [Home Footer Desktop Banner](https://acuity.news/ad-group/home-footer-desktop/) - [Home Footer Mobile](https://acuity.news/ad-group/home-footer-mobile/) - [Article Banner Desktop](https://acuity.news/ad-group/article-desktop/) - [Article Banner Mobile](https://acuity.news/ad-group/article-mobile/) ## Topics - [Behavioral Health](https://acuity.news/topic/behavioral-health/) - [Applied Behavior Analysis](https://acuity.news/topic/applied-behavior-analysis/) - [regulation](https://acuity.news/topic/regulation/) - [Healthcare Economics](https://acuity.news/topic/healthcare-economics/) - [Private Equity](https://acuity.news/topic/private-equity/) ## Optional - [Sitemap index](https://acuity.news/sitemap_index.xml)